NovoCure NVCR Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$15.66M+61.0% | -$71.14M-107% | -$24.5M+62.8% | -$37.27M-21.9% | -$40.14M-20.3% | ||
| $4.31M+25.1% | $4.12M+24.0% | $4.22M+35.9% | $3.66M+49.0% | $3.44M+20.5% | ||
| $17.01M-34.9% | $63.01M+113% | $19.82M-68.4% | $29.32M-6.5% | $26.14M-17.9% | ||
| $8.13M+151% | -$13.52M+62.1% | -$18M-422% | $20.57M+98.3% | -$15.94M-827% | ||
| $6.92M+26.1% | $5.15M-51.4% | $4.9M-45.2% | $5.66M-47.1% | $5.49M-52.1% | ||
| -$6.38M-118% | $7.75M+220% | $336.33M+1,614% | $71.44M+601% | $35.99M+110% | ||
| $0— | $0— | $0— | $99.98M— | $0-100% | ||
| $0— | $0— | $560.95M— | $0— | $0-100% | ||
| $4.55M+90.5% | -$166K-103% | -$559.49M-20,938% | $100.52M+100,417% | $2.39M-97.3% | ||
| $6.29M-72.3% | -$6.07M+83.5% | -$241.25M-944% | $192.51M+827% | $22.7M+108% | ||
| $1.22M+106% | -$18.67M+59.7% | -$22.9M-84.8% | $14.92M+4,960% | -$21.42M-62.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does NovoCure generate?
- NovoCure (NVCR) generated -$2.8M in operating cash flow over the trailing twelve months.
- What is NovoCure's free cash flow?
- After $22.6M of capital expenditures, NovoCure's free cash flow was -$25.4M over the trailing twelve months, up 68.4% year over year.
- Where does NovoCure's cash flow data come from?
- Every line is extracted from NovoCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
